International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) is in a basing phase after dropping to deep value levels, which is inherently intriguing as we see it. That is especially true given that the stock is now holding support for the past few weeks, breaking out of the downward trending mode. When a deep value play – and this is obvious here – begins to put in a basing support structure, it’s usually a good idea to start paying close attention.
The reason we say that it’s obvious this is a deep value play should be clear after a moment of investigation. This company is actually doing very well over the past six months. Sales are growing extremely fast on the top line, and the flow to the bottom line has picked up enough to push the company into the black on a gross and EBITDA basis.
International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH) bills itself as a diversified brand incubator with operations in two primary divisions, together spanning the Spirits, Home Healthcare Services, and CBD-Based Products markets worldwide.
The Spirits Division imports, licenses, and markets premium beverage brands, with sales of innovative products and brands, including its award-winning premium Besado Tequila brand.
The Company’s Home Healthcare Services segment provides care for clients in need of healthcare and caretaking services outside of established medical facilities. The Company continues to increase both its fleet of caretakers providing services and its total clientele.
The CBD-Based Products segment is focused on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations for sale under the “P19” brand designation. This line of products is formulated and marketed in partnership with BioPulse Labs, a leader in cutting-edge CBD nano-infusion formulation technology and CBD-based product brand development.
The company has also partnered with Bengala Technologies in the development and commercialization of enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.
Find out when $ISWH reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
To help really build out the story, ISWH just announced the full execution by all parties of a partnership agreement with BioPulse Labs, a leader in cutting-edge CBD nano-infusion formulation technology and CBD-based product brand development.
Terry Williams, CEO of ISWH, commented, “BioPulse has the experience and capability to step in and help take our CBD-based products segment to a new level as we navigate this critical stage and transform enormous potential into accelerating revenue growth. This step will position our P19 brand as a differentiated product, both in terms of product quality through superior bioavailability and in terms of brand recognition, given BioPulse’s nationwide marketing and distribution footprint.”
As discussed above, this would appear to be a classic value opportunity. But it is a micro-cap, so discretion and due diligence is always advised. Here, we would point out that debt has been shrinking and the company has actually put out positive guidance for Q4 based on a jump in its spirits segment sales and a resumption of sales in its CBD segment.
Earning a current market cap value of $375K, ISWH is pulling in trailing 12-month revenues of $353K. In addition, the company is seeing recent top-line growth, with sequential quarterly revenues growing at 28%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $ISWH stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $ISWH, either long or short, and we have not been compensated for this article.